Fasken Martineau DuMoulin LLP advised the Underwriter in connection with Medexus Pharmaceuticals’s offering. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) closed its bought-deal public offering of 3,389,900...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised the sole agent and sole bookrunner. On July 4, 2022, Algernon Pharmaceuticals Inc. (CNSX:AGN) announced the closing of its previously announced marketed...
You must be a Standard 1 Year member to access this content.
Fasken acted for Echelon Wealth Partners Inc. on the transaction. On November 24, 2021, ProStar Holdings Inc. (CVE:MAPS) completed a brokered C$5.75 million private placement of units. Echelon...
You must be a Standard 1 Year member to access this content.
Gibson Dunn, working closely with Fasken Martineau DuMoulin LLP and Jeausserand Audouard, assisted Anjac in the acquisition of Apollo Healthcare Corp., represented by Miller Thomson LLP....
You must be a Standard 1 Year member to access this content.
Fasken acted for a syndicate of agents led by Echelon Wealth Partners Inc. On May 6, 2021, VOTI Detection Inc.(TSXV:VOTI), a Canadian x-ray security screening solution...
You must be a Standard 1 Year member to access this content.
